<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="170">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 08, 2015</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01260571</url>
  </required_header>
  <id_info>
    <org_study_id>EAA 554-10/v6</org_study_id>
    <nct_id>NCT01260571</nct_id>
  </id_info>
  <brief_title>Clinical Study to Evaluate the Efficacy of Topical Medications Containing Benzoyl Peroxide and Sulfur in the Regression in the Short Time (24 Hours) of Moderate Acne Vulgaris Grade II (Pimples)</brief_title>
  <official_title>Clinical Study to Evaluate the Efficacy of Topical Medications Containing Benzoyl Peroxide and Sulfur in the Regression in the Short Time (24 Hours) of Moderate Acne Vulgaris Grade II (Pimples)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zurita Laboratorio Farmaceutico Ltda.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zurita Laboratorio Farmaceutico Ltda.</source>
  <oversight_info>
    <authority>Brazil: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sixty two subjects will take part in this study. The study is unic arm. The subjects used
      the product once and will be evaluated in the regression of pimples in the times 0,4,6,8 and
      24 hours after application.

      A follow-up visit will be made 24 hours after initiation of treatment.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Anticipated">March 2011</completion_date>
  <primary_completion_date type="Anticipated">March 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Clinical study to evaluate the efficacy of topical medications containing benzoyl peroxide and sulfur in the regression in the short time (24 hours) of moderate acne vulgaris grade II (pimples).</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Clinical evolution of the target lesions for each experimental time regarding the parameters of reddening, size and general appearance of the lesion.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">62</enrollment>
  <condition>Treatment of Acne Vulgaris Grade II in a Short Period of Time.</condition>
  <arm_group>
    <arm_group_label>Benzoyl Peroxide and Sulfur</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Topical Medications containing benzoyl peroxide and sulfur</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Benzoyl peroxide and sulfur</intervention_name>
    <description>topical cream, 5% benzoyl peroxide and 2% sulfur Frequency once to day Duration 24 hours</description>
    <arm_group_label>Benzoyl Peroxide and Sulfur</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects of both sexes aged to 12 years to 35 years

          -  Oily skin prone to acne

          -  Presence of at least three inflammatory lesions, diagnosed as grade II acne vulgaris.

          -  Sign the informed Consent Form

          -  Comply the requirements and attend to study visits

        Exclusion Criteria:

          -  Pregnancy (need for urinary pregnancy test for women of childbearing age)

          -  Lactation

          -  Presence of acne conglobata and nodulocystic

          -  Pathologies associated hormonal (thyroid diseases, ovaries micropolycystic)

          -  Drug use systemic corticosteroids, anticonvulsants and / or new drugs for up to one
             month before to selection.

          -  History of atopy or allergic cutaneous

          -  History of hypersensitivity to benzoyl peroxide and sulfur

          -  Beginning or ending the use of contraceptives (for females)

          -  Intense sun exposure until one month before the evaluation
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sergio Schalka, Doctor's</last_name>
    <phone>(11) 36816362</phone>
    <email>medcin@medcinonline.com.br</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medcin Instituto da Pele</name>
      <address>
        <city>Osasco</city>
        <state>SÃ£o Paulo</state>
        <zip>06023-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sergio Schalka, Doctor's</last_name>
      <phone>(11) 36816362</phone>
      <email>medicin@medicinonline.com.br</email>
    </contact>
    <investigator>
      <last_name>Sergio Schalka, Doctor's</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>September 2010</verification_date>
  <lastchanged_date>December 14, 2010</lastchanged_date>
  <firstreceived_date>December 13, 2010</firstreceived_date>
  <responsible_party>
    <name_title>Sergio Schalka</name_title>
    <organization>Medicin Skin Institute</organization>
  </responsible_party>
  <keyword>blackheads and pimples</keyword>
  <keyword>Acne vulgaris grade II</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acne Vulgaris</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Benzoyl Peroxide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
